Physician profile
Omar Baber
NPI 1457799850
$5,650.70
in general payments reported to CMS, 2019-2025
18 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.30 · 2020: $15.59 · 2021: $179 · 2022: $3,639 · 2023: $682 · 2024: $373 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,395.97 | 2022-2025 | Diamondback Coronary, Perclose Prostyle |
| Abiomed | $910.20 | 2021-2025 | Impella |
| Medtronic, INC. | $549.44 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Micra |
| Teleflex LLC | $448.13 | 2022-2023 | Arrow |
| Boston Scientific Corporation | $382.17 | 2022-2023 | Crossboss, Opticross, Rotablator Rotational Atherectomy System Console Kit |
| Stryker Corporation | $221.03 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Cardiovascular Systems INC. | $180.11 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.85 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $152.16 | 2024 | |
| Novartis Pharmaceuticals Corporation | $44.08 | 2025 | |
| Chiesi USA, INC. | $34.87 | 2022-2025 | Kengreal, Cleviprex |
| Merck Sharp & Dohme LLC | $34.13 | 2024 | Verquvo |
| Asahi Intecc USA, INC. | $33.19 | 2023 | Asahi Ptca Guide Wire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.30 | 2019 | |
| Cardiva Medical, INC. | $23.23 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $18.75 | 2024 | |
| Amgen INC. | $17.50 | 2025 | Repatha |
| Terumo Medical Corporation | $15.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Baber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.